Abstract
Introduction
Over the past few decades, improvement of modern intravenous therapy has transformed medical practice and drug development. The parenteral route of drug administration is preferred in situations that require rapid systemic response to medications. However, intravenous therapy also comes with potentially significant risks. Drugs administered intravenously have the potential to escape the venous system and leak into the surrounding tissue. Depending on the type of medication involved, this event can be described as extravasation or infiltration. Extravasation is the leakage of a vesicant into the surrounding tissue. Vesicants are agents that can damage soft tissue by causing blistering and tissue necrosis. 1 The morbidity of this complication is substantial because the wound can progress and worsen over a course of weeks to months. 1 Infiltration is the leakage of an irritant from the blood vessels to surrounding tissues. Both irritants and vesicants can cause inflammation and pain, but irritants do not cause tissue necrosis. 1
Identifying risk factors is an essential step in effectively preventing extravasation. Sauerland et al 2 summarize a comprehensive list, including device-related, therapy-related, patient-related, and clinician-related risk factors. The use of large-gauge or metal needles for peripheral IVs can be traumatic to veins. Displacement or occlusion of central venous catheters as a result of thrombus formation or fibrin sheaths can lead to extravasation. Placement of IV lines in areas of joint flexion such as the hand or wrist has been associated with an increased risk of IV-associated complications. The risk of extravasation is also increased in patients who are very young or very old. Finally, the vesicant potential, concentration, and duration of infusion of the infused agent should all be considered.1-3
Most described cases of extravasation involve cytotoxic agents. The incidence of extravasation resulting from chemotherapy or cytotoxic vesicants is reported to be between 0.01% and 6%. 2 However, the incidence remains largely unknown for extravasation involving noncytotoxic agents. A significant number of commonly used noncytotoxic intravenous medications have been reported to possess vesicant properties, including high osmolarity, extreme acidic or basic pH, and/or vasoconstrictive activity.3-7
The reporting of extravasation caused by noncytotoxic agents is limited to mostly case reports and anecdotal evidence. Therefore, the recommended management of extravasation for each drug is sparse and oftentimes conflicting. In an effort to provide a consolidated and more comprehensive view of management strategies for noncytotoxic extravasation, we have summarized the available literature.
Criteria for Selection and Assessment of the Literature
We performed a literature search limited to articles written in English using PubMed with the following key words: extravasation, soft tissue injury, phlebitis, and infiltration from January 1961 through January 2014. Distinction between extravasation and infiltration in the literature is often misleading, especially when the authors inadvertently mislabel true extravasation for infiltration or vice versa. Therefore, we expanded our search terms to include phlebitis and infiltration. This produced more than 8000 publications. The publications were screened manually and reviewed to identify reports for medications that included synonyms of the International Nonproprietary Name; by excluding reports of antineoplastic agents, radiographic contrast material, investigational or nonmarketed drugs, and animal data, 70 articles were identified. Furthermore, reference citations from publications were also reviewed for relevance and yielded 4 articles.
Vesicants in the Literature
Properties Associated With Vesicants
The mechanism of tissue damage from noncytotoxic agents is contingent on several drug-specific properties, including osmolarity, pH, and mechanism of action. Osmolarity is a measure of solute concentration expressed as milliosmoles per liter of solution (mOsm/L; physiological range = 285-310 mOsm/L). Animal data suggest that extended infusions of hyperosmolar solutions (>600 mOsm) are associated with higher risk of endothelial damage. 8 Tissue damage can occur from fluid shifts in or out of cells as a result of large differences in osmolarity. 9 Furthermore, increased osmotic pressure can compress and damage blood vessels, nerves, and muscle tissue. Vesicant potential is also determined by the pH of a drug solution. Agents that are extremely acidic or basic relative to physiological pH can be caustic to endothelial tissue.9,10
Vasoactive drugs induce local tissue ischemia through vasoconstriction of blood vessels. 9 In addition, the drug diluent has been thought to be the cause of vascular damage. Inactive ingredients such as benzyl alcohol and propylene glycol can induce inflammatory responses that may contribute to tissue injury.11,12
Reported Cases of Extravasation
There were a total of 232 cases of extravasation (Table 1). Of these, 105 cases occurred in adults, 5 cases in adolescents, 10 cases in children, 15 cases in infants, and 36 cases in neonates. Among the 61 cases reported with unspecified age, 22 included individuals younger than 18 years. All reported published cases of extravasation were noted in Table 1, but only agents described in case reports were expanded on in the text. Table 2 describes agents used as antidotes in the management of extravasation.
Noncytotoxic Vesicants Reported in the Literature.
Abbreviations: mOsm: osmolarity (mOsm/L); TPN, total parenteral nutrition.
Neonate: <1 month of age; infant: 1-12 months of age; child: 1-12 years of age; adolescent: 12-18 years of age; adult: >18 years of age.
Amiodarone contains benzyl alcohol, which may contribute to its vesicant properties.
Phentolamine is the preferred antidote for these extravasations; terbutaline has been used during phentolamine shortage.
Pharmacological Agents Used in the Management of Extravasation.
Anti-infectives
Acyclovir
Acyclovir is an antiviral nucleoside analog effective in the management of herpes simplex virus, varicella zoster virus, and cytomegalovirus. Intravenous acyclovir has a pH of 11 and an osmolality of 278 mOsm/kg at a concentration of 7 mg/mL in dextrose 5%. 13 Only 1 case of acyclovir extravasation has been reported to date. De Souza and Shibu 14 describe a 51-year-old man who sustained an acyclovir extravasation injury in his left hand during treatment for ophthalmic herpes zoster. No extravasation treatment was administered when the event occurred. The patient was readmitted 3 months later for treatment of left-hand cellulitis. There was no evidence of tissue necrosis or ulceration. The authors suggest the injury to be severe chemical inflammation caused by the alkaline acyclovir solution. The wound was managed with physical therapy and compression garments.
Amphotericin
Amphotericin B is a broad-spectrum antifungal agent. Amphotericin B has a pH between 5 and 6 and an osmolality of 256 mOsm/kg. 13 Although the vesicant potential should be low based on these drug-specific properties, it is unclear why amphotericin B causes thrombophlebitis and chemical irritation when extravasated. 15 There is only 1 report of amphotericin B extravasation. Olson and McCoy 16 describe a case of inadvertent extravasation of 40 mg of amphotericin B in 250 mL of dextrose into the right antecubital area. At the end of the 3-hour infusion, the patient reported symptoms of pain and swelling. The patient was instructed to elevate the arm. Cold compresses were used initially but then were switched to warm compresses by day 2. All supportive care was discontinued on day 3. The area of extravasation completely resolved after 5 months. In this case, the proposed mechanism of tissue damage from extravasation was mechanical compression as a result of increased fluid in the interstitial space.
Metronidazole
Metronidazole is an antimicrobial agent active against anaerobic organisms, Clostridium difficile, and protozoa. The intrinsic properties of intravenous metronidazole, including a pH of 5.5 and an osmolarity of 310 mOsm/L, would not identify metronidazole as having the potential to cause tissue necrosis. To date, there is only 1 published case of metronidazole extravasation. Bharani et al 17 describe the development of gangrene in nearly all fingers after 50 mL of metronidazole extravasated into the dorsum of the right hand, which was initiated for symptoms of fever, diarrhea, and worsening abdominal distension. In this case, treatment with aspirin, pentoxifylline, and nifedipine did not prevent gangrene formation. 17
Nafcillin
Nafcillin is a β-lactam penicillin that is active against streptococci and staphylococci infections through its ability to interfere with bacterial cell wall synthesis. Tissue injury caused by nafcillin extravasation and phlebitis has been documented in a handful of case reports.18-21 However, the mechanism of cell damage is not entirely known. It is neither acidic nor basic, with a reconstituted pH ranging from 6 to 8.5. 13 In case reports, the final concentrations of nafcillin were well below the maximum recommended concentration of 64 and 71 mg/mL in dextrose 5% and 0.9% sodium chloride, respectively. However, animal studies have shown that tissue necrosis may occur with infusions diluted to concentrations per manufacturer’s guideline. 18 The only antidote reported to have been used for the management of nafcillin extravasation is hyaluronidase. By facilitating the diffusion of extravasated fluids into surrounding tissue, hyaluronidase allows for rapid absorption and minimizes further tissue damage. Other suggested treatment options include cold compresses and sulfadiazine silver cream.18,19
Oxacillin
Oxacillin, a β-lactam penicillin, is closely related to nafcillin and used mainly to treat infections related to Gram-positive organisms. Oxacillin has a pH of approximately 4.8 to 5.7 and an osmolarity ranging between 326 and 379 mOsm/kg per 1 g of oxacillin in 50 mL of sodium chloride 0.9% or dextrose 5%. 13 These properties do not lend themselves to oxacillin being extremely caustic to venous epithelial cells. There is only 1 published report of oxacillin extravasation. In this case, oxacillin was administered through a left antecubital vein. Extravasation was noticed after the second dose when the surrounding area of infusion was notably red and painful. The lesion progressively worsened to an 8 × 6 cm2 area with tissue necrosis. Given the limited extent of extravasation, the course of treatment followed supportive care with topical steroids, cold compresses, and silver sulfadiazine dressings instead of surgical intervention. The area eventually healed leaving behind a small scar. 22
Vancomycin
Vancomycin inhibits cell wall synthesis and is effective against Gram-positive organisms such as nosocomial staphlyococci and enterococci. Because of its poor oral bioavailability, vancomycin is primarily administered intravenously, except in the treatment of Clostridium difficile. Vancomcyin solution is acidic (pH of 2.5-4.0) 13 and hyperosmolar (328 mOsm/L) 13 when concentrated to 10 g/L for central venous catheter administration. 13 Such an acidic and hyperosmolar solution has the potential to be a vesicant when administered through a peripheral line. 23
A case published by Hoelen et al 24 described the development of an ischemic lesion at the dorsum of the patient’s left foot 48 hours after the start of vancomycin therapy. Vancomycin was immediately withdrawn, and the lesion resolved without any further intervention. Bohm and Wong 25 reported a case of linear IgA bullous dermatosis that occurred in a 72-year-old woman after the majority of a 1-g intravenous dose of vancomycin extravasated into her right upper arm. The lesions were described as vesicles accompanied by redness, swelling, and hyperpigmentation. The site of extravasation gradually improved after local wound care and arm elevation.
Antiarrhythmics
Amiodarone
Amiodarone is one of the most widely used anti-arrhythmic agents available and is effective for a variety of arrhythmias. In emergent situations, amiodarone is given undiluted through a peripheral intravenous line. Amiodarone has a pH of 4.08 and contains polysorbate and benzyl alcohol as part of the diluent. 13 There is only 1 known published case report of amiodarone extravasation to date. In the setting of cardiac arrest, an amiodarone bolus of 300 mg followed by a 900-mg infusion over 23 hours was administered through a peripheral line. The authors attribute the development of severe blistering and skin necrosis on the right forearm approximately 1 day after the start of infusion to amiodarone extravasation. Treatment with hot or cold packs and topical steroid cream were recommended by the manufacturer. 11
Adrenergic Agents
Dobutamine, Dopamine, Epinephrine, and Norepinephrine
Dobutamine, dopamine, epinephrine, and norepinephrine are vasoactive agents widely used for cardiovascular syndromes. In emergent settings secondary to hemodynamic instability, administration of vasopressors may be limited to a peripheral line because of lack of a central line access. At varying degrees of potency, all 4 agents stimulate α-adrenergic receptors and are, therefore, considered to be effective vasoconstrictors. 26 Extravasated vasopressors can propagate cell damage by inducing venous and arterial vasospasms and causing disruption to vein wall integrity. 27 All 4 agents are considerably acidic, with dopamine having a pH of about 3.3, epinephrine a pH of 2.2 to 5.0, norepinephrine a pH of 3.0 to 4.0, and phenylephrine a pH of 3.0 to 6.5. 13 It is widely known that extravasation of these vasopressors can cause significant tissue damage, skin sloughing, and dermal necrosis.5,27-44 This is true for dopamine even at low doses, where there is minimal α-adrenergic activity. 30
Phentolamine is the only FDA-approved antidote for the treatment of α-adrenergic agonist drug extravasation. As an α-receptor antagonist, phentolamine competitively works against circulating catecholamines and is effective in partially reversing ischemic changes caused by dopamine-induced extravasation. It is most effective when injected subcutaneously into the surrounding area within 12 hours of extravasation. Negligible side effects have been reported with the use of phentolamine.31-34,45
In situations when phentolamine is unavailable, terbutaline, a pure β2-agonist, has been reported to be successful in reversing local vasoconstriction. The vasodilatory effect of terbutaline attenuates vasoconstriction caused by α1-agonism. Terbutaline 1 mg can be diluted to either a 1:10 concentration in normal saline for larger affected areas or 1:1 concentration for localized ischemia, such as in a finger. Terbutaline should be used with caution in patients with underlying cardiovascular disease because of the risk of arrhythmias and myocardial ischemia. 35
Topical nitroglycerin has been reported to be effective in reversing ischemic changes of extravasated dopamine in situations where local injection of phentolamine was considered inappropriate. Denkler and Cohen 36 describe the use of topical nitroglycerin for the treatment of dopamine extravasation into the dorsum of the left hand and the left ankle of a premature infant. A 1-inch strip of 2% topical nitroglycerin was applied to both sites approximately 2 to 3 hours after symptoms of extravasation were noticed. Within a few hours, symptoms at both sites resolved, and the areas of extravasation appeared normal. Wong et al 40 reported successful use of 4 mm/kg of 2% nitroglycerin for treatment of dopamine extravasation in neonates, with no hemodynamic side effects noted. Sodium nitroprusside, on the other hand, was found to be ineffective despite its potent vasodilating properties. Supportive care measures with warm compresses, elevation of the affected limb, and wound care can also facilitate healing.30,37,38
Vasopressin
Vasopressin is a peptide hormone released from the posterior pituitary gland in response to decreased intravascular volume, osmolarity, and/or pressure. In the setting of hemodynamic instability, low-dose exogenous vasopressin can increase systemic vascular resistance and decrease the requirements for catecholamines.
Depending on the indication, vasopressin can be administered via many different routes, including intravenously, intramuscularly, or subcutaneously. Vasopressin has a pH of 2.5 to 4.5 and is generally diluted to a concentration of 0.1 to 1 unit /mL when administered as an infusion. 13 Although there is no direct correlation between vasopressin concentration and extent of tissue damage with extravasation, 1 case of severe tissue necrosis has been reported. Kahn et al 46 report a case of vasopressin infused at 0.04 units/min through a peripheral line in the setting of refractory septic shock. Progressive tissue damage continued to occur despite stopping the infusion and applying warm compresses as treatment. No other published studies of low-dose vasopressin extravasation have been reported. Although not commonly recommended, administration of low-dose vasopressin through a central line for septic shock would be an option to avoid this complication. 46 Cases of cutaneous gangrene have been reported in a small number of patients who were receiving vasopressin 20 units/hour for the treatment of portal hypertension. It is important to note that the causative agent for cutaneous gangrene in 4 out of the 5 cases cannot be clearly linked to vasopressin extravasation and remains unclear. 47
Electrolytes/Hyperosmolar Agents
Mannitol
Mannitol is an osmotic diuretic that works directly at the proximal tubule and descending loop of Henle in the kidneys to prevent the reabsorption of free water and sodium. This type of diuresis is useful in situations where increased urinary excretion is necessary and to reduce elevated intracranial pressure secondary to head injuries. Mannitol solutions are hyperosmolar (1098 mOsm/L) 13 and can cause swelling and severe edema by drawing fluid into the extravasated tissue. The increased pressure from edema can lead to compartment syndrome characterized by reduced blood flow, tissue necrosis, and nerve damage.
In cases of diagnosed compartment syndrome, emergent fasciotomy is required to relieve fluid pressure. This procedure is often traumatic and potentially disfiguring.48-51 For less severe cases of extravasation, the use of hyaluronidase and warm compresses has been reported. 52 Kumar and Sprung 52 report the extravasation of 20% mannitol in the dorsal right hand of a man undergoing general anesthesia for a procedure. The patient experienced significant swelling in his hand with delayed capillary filling. When treatment with warm compresses and elevation failed to provide relief, 150 units of hyaluronidase was injected subcutaneously in 0.5- to 1.0-mL increments to the periphery of the site. Complete resolution of the area occurred the following day, and no surgical intervention was required.
Parenteral Nutrition and Electrolytes
Hypertonic agents such as total parenteral nutrition (TPN),5,53-56 dextrose >10%,57,58 calcium solutions,57,59-61 potassium solutions,5,57,62,63 and sodium bicarbonate5,57,59,62 exhibit the potential to cause tissue damage by shifting the equilibrium between intracellular and extracellular fluid. Intracellular fluid is forced out of cells and into the interstitial space, causing direct cell damage. In addition, increased fluid and pressure can lead to acute limb compartment syndrome with damage to the surrounding muscle and nerves. Inadvertent leakage of these agents has been reported to cause significant sequelae, especially in the neonatal population. Skin grafting, wound debridement, and limb amputation have all been reported as necessary treatment options.53,57,64,65 Noninvasive therapies with topical nitroglycerin to prevent tissue ischemia and amorphous hydrogel to promote wound autolysis have been successfully used to treat TPN extravasation in neonates.54,55 Wiegand and Brown 66 report complete resolution with the use of hyaluronidase and cold compresses for the treatment of dextrose 5% solution extravasation.
Calcinosis cutis, a term used to describe a rare condition of calcium deposition in the skin, was first described in 1936 and has since been well described in the literature as a result of calcium solution extravasation.56,67-77 The formation of amorphous masses or diffuse subcutaneous plaques may take days to weeks to develop, appearing as firm, white to yellow nodules on the skin. 67 There is no standard treatment for calcinosis cutis. Supportive care with arm elevation and cold compresses has been recommended. 74 Surgical removal of the calcium deposit may be necessary. 70
Other Agents
Arginine
Phenytoin
Phenytoin is one of the most widely used antiepileptic drugs available. Phenytoin sodium, the injectable form, is most commonly used to control status epilepticus in patients who are hospitalized or unable to tolerate any medication by mouth. Each 50 mg/mL vial of phenytoin solution contains approximately 40% propylene glycol and 10% alcohol adjusted to a pH of 12 with sodium bicarbonate. 13 Because of its poor solubility and tendency to precipitate, intravenous phenytoin should be administered using an in-line 0.22- to 5-µm filter at a maximum rate of 50 mg/min to avoid systemic toxicity. The proposed mechanism of tissue damage from extravasation involves all the aforementioned properties: vehicle composition, strongly alkaline pH, and precipitate-forming abilities.
Many cases of phenytoin extravasation have been reported.83-89 Rao et al 84 reported 3 cases of phenytoin extravasation with different interventions and varying degrees of severity. In the most severe case, a fasciotomy was performed after the patient experienced rapid swelling and discoloration of the hand from phenytoin extravasation. Despite aggressive surgical intervention, the patient eventually developed necrosis at the fingertips and distal forearm requiring amputation of the hand. In mild cases of phenytoin extravasation, elevation of the affected limb and close observation is recommended and reportedly successful. Risk factors for phenytoin extravasation include undiluted administration, small IV catheters, and rapid infusion greater than 25 mg/min. 85
Hyaluronidase has been used for the treatment of extravasated phenytoin successfully. In 1 case report involving extravasation in a pediatric patient, repeated doses of subcutaneous hyaluronidase administered into sites surrounding the area resulted in decreased swelling and complete resolution. Other treatment options described include warm compresses and transdermal nitroglycerin patches.83,86-89
Promethazine
Promethazine is a common drug used as an antiemetic, antihistamine, and sedative. Although promethazine is available in tablet, liquid, suppository, and injection forms, the intravenous route is the most popular route of administration primarily because of its rapid onset of action. Intravenous promethazine made headline news across the country in early 2000 when cases of intravenous promethazine extravasation caused severe tissue gangrene that required amputation. A 19-year-old patient was given IV promethazine in the emergency department for nausea. The drug extravasated during administration. The resulting necrosis was so severe that 3 fingers were eventually amputated. IV promethazine is highly irritating and acidic, with a pH of 4 to 5.5. 13 According to a safety report published by the Institute for Safe Medication Practices, 3 incidences of promethazine extravasation required amputation.80,91
The significant morbidity of this error has led to widespread education and change in clinical practice. The preferred route of administration for parenteral promethazine is intramuscular. However, if intravenous promethazine is used, the maximum recommended concentration should be 25 mg/mL. Administration should be through large, patent veins, given slowly over 10 to 15 minutes and preferably diluted to enable slow administration. More drastic changes to clinical practice include removing promethazine from the formulary or prohibiting use of the IV route.80,91
Propofol
Propofol is a common anesthetic used for general sedation and for sedating mechanically ventilated patients in the intensive care unit. Propofol seems innocuous, being isotonic and having neutral (pH of 7-8.5) chemical properties. 13 However, a handful of cases involving tissue damage and necrosis with propofol extravasation have been reported.92-98 In the case of a patient receiving propofol for mechanical ventilation, a blister with underlying necrotic tissue developed at the site of infusion. Supportive therapy with limb elevation and wound dressings were applied with complete resolution. 95 Another case of tissue necrosis associated with propofol extravasation was described in an infant during general anesthesia. Early signs of tissue necrosis in the right foot required wound debridement and skin grafting by plastic surgery. 96 Supportive care with cold compresses was used by Huijbers et al 97 for a patient when propofol extravasated into the back of the patient’s left hand during general anesthesia. The patient reported significant pain, but no soft-tissue damage was noted. The area completely resolved with no permanent sequelae.
Sodium Valproate
Valproic acid therapy is used to treat both seizures and mood disorders. Sodium valproate solution for injection (valproic acid) has a pH of 7.6. 13 Maintenance doses of sodium valproate should be administered at a rate of no more than 20 mg/min. However, in urgent situations, sodium valproate may be given as a rapid infusion at up to 6 mg/kg/min. Rapid administration of sodium valproate into a peripheral line is known to commonly cause pain and irritation. 99 However, extravasation or infiltration of valproic acid into surrounding tissue has rarely been reported. Santivasi et al, 100 in a case report, described a patient who developed large fluid-filled bullae after an infusion of 500 mg of valproic acid in 50 mL of dextrose through a peripheral line placed in his right hand. Edema at the site of extravasation progressed into the upper extremity, leading to compartment syndrome. The patient required emergent escharotomy to relieve tissue pressure. Although the exact mechanism of tissue damage is unknown, the authors note contributing factors to include local infusion accumulation, direct toxic effects, and possibly low tissue carnitine levels as a result of long-term valproic acid therapy. 100
Sodium Thiopental
Sodium thiopental is a fast-acting barbiturate used for the induction of general anesthesia and is more commonly known to cause thrombophlebitis.101,102 On the other hand, extravasation management is limited to the experience of 1 case report. Mao et al 101 reported the use of 2% lidocaine injected into the affected catheter and 15 g EMLA cream applied over the affected area for the treatment of suspected extravasation. The area completely resolved after 48 hours with no long-term sequelae. 102
Agents Reported to be Vesicants
The agents listed in Table 3 have been reported to be considered vesicants by review articles.1,7,45,65 A PubMed search of each of these agents yielded no published reports. A review of package inserts revealed extravasation and/or phlebitis warnings for only doxapram, phenylephrine, and piperacillin/tazobactam.104-106 The potential vesicant properties of these agents and management are listed in Table 3.
Noncytotoxic Agents With Vesicant Potential or That Have Been Reported to Cause Irritation, Phlebitis, or Necrosis With Extravasation.
Discussion
Extravasation of intravenous vesicants can cause significant morbidity if left untreated. Data supporting the management of extravasation for noncytotoxic agents are limited, and management is often extrapolated from other drugs, with variable results. Recognition of potential vesicants and identification of patient-specific risk factors remain essential in the prevention of extravasation.
In the event where extravasation has occurred, treatment requires prompt attention. To minimize tissue damage, the infusion should be stopped immediately and disconnected from the catheter or needle. An attempt to aspirate any residual drug using the catheter or needle should be done to further decrease the amount of extravasated fluid. If possible, the affected extremity should be elevated to minimize swelling. Assessment for need of an antidote or surgical management should be made by the physician. In addition, the use of supportive measures such as cold or warm compresses should be considered.4,7,107
Pharmacological management with antidotes may be warranted in certain cases, and these are listed in Table 3. Hyaluronidase is an enzyme that degrades hyaluronic acid of connective tissue and promotes the dispersion and absorption of the infiltrated drug. 108 Data from animal models and numerous case reports have shown hyaluronidase to decrease the area of necrosis when administered to the surrounding area of extravasation. Hyaluronidase has been reported to have been used for extravasation of many agents, including dextrose, mannitol, nafcillin, and phenytoin. Based on its mechanism of action, hyaluronidase can theoretically be effective in extravasation management of any intravenous drug if the goal is to cause distribution of the irritating medication away from the affected site. Phentolamine is the preferred antidote for vasopressors because of its effective ability to reverse the α1-mediated vasoconstriction properties of vasopressors. Terbutaline, a β2 agonist, has been used in place of phentolamine where phentolamine was not available. Topical nitroglycerin has also been used for local vasodilatory effects. Silver sulfadiazine is a topical antimicrobial agent, whose use is often reported for the management of local tissue damage.
The decision to use cold or warm compresses remains controversial. Warm compresses can increase blood circulation and encourage drug dispersal away from the affected area; however, an increase in tissue maceration and necrosis has been reported.7,109 Cold compresses can induce vasoconstriction and limit the damage to surrounding tissue; however, it could potentially increase tissue damage.7,110 Hastings-Tolsma et al 111 found a significant reduction in infiltrated volume with the use of warm compresses when used on varying concentrations of sodium chloride infiltrations. There was no difference in pain intensity with either warm or cold compresses. It was also noted that on average, 3% sodium chloride (1027 mOsm) infiltration doubled in size by 72 minutes postinfiltration with either warm or cold compresses, whereas the 0.45% sodium chloride (154 mOsm) and 0.9% sodium chloride (308 mOsm) infiltration volumes were reduced over the same time.
Compresses can be used in conjunction with antidotes when the goal is the same. The intrinsic properties of the extravasated drug should dictate the need for a cold compress (localize the agent) or a warm compress (disperse the agent). Warm compresses should be concomitantly applied with hyaluronidase to facilitate the dispersion of the vesicant away from the site of extravasation to limit tissue damage. The use of hyaluronidase with cold compresses appears to be counterintuitive because they are theoretically opposite in action. Topical nitroglycerin can provide an alternative modality of treatment by increasing blood flow and potentially reversing vasoconstriction. 112 Additional supportive care with a topical corticosteroid cream to reduce inflammation and silver sulfadiazine cream to prevent infection can promote wound healing.
Prevention of extravasation remains the most important step in the overall management of extravasation. Recognition of drugs that are vesicants or pose the risk of becoming a vesicant is critical to be able to effectively and actively prevent extravasation. Noncytotoxic vesicants should be identified and labeled correctly prior to dispensing. Nurses who administer vesicant agents should be trained to follow procedures similar to those of cytotoxic vesicants. This involves assessing veins for patency, placing IV lines in proper areas, and assessing for pain during and after the infusion.
Summary
With limited data available, the management of extravasation from noncytotoxic agents remains controversial. For all ages, extravasation is most commonly found with phenytoin, parenteral nutrition, and electrolytes (calcium and potassium) and can lead to patient discomfort, significant tissue damage, or even amputation. Fortunately, this adverse outcome is preventable, and identification of vesicant agents plays a pivotal role. The intent of this review was to provide a reference identifying noncytotoxic vesicants and guidelines for the management of extravasations associated with specific agents.
Footnotes
Acknowledgements
The authors would like to thank Denise Kwong, PharmD, for her expert assistance in the preparation of the manuscript.
Authors’ Note
This article is the first to review and compile data regarding extravasation of noncytotoxic drugs.
Declaration of Conflicting Interests
The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Funding
The author(s) received no financial support for the research, authorship, and/or publication of this article.
